Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
BackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.Methods...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/full |
_version_ | 1811340780247187456 |
---|---|
author | Wenjing Duan Yongguang Yang Jingge Zhao Tianzhong Yan Xiangyong Tian |
author_facet | Wenjing Duan Yongguang Yang Jingge Zhao Tianzhong Yan Xiangyong Tian |
author_sort | Wenjing Duan |
collection | DOAJ |
description | BackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.MethodsNineteen KTRs with RUTI were collected in this study. The uropathogens were detected and compared by mNGS and urine culture, respectively. Modifications of the anti-infection strategy were also assessed.ResultsRich and diverse pathogens were revealed by mNGS. mNGS was significantly higher than culture in total positive rate (100.0% vs. 31.6%; p < 0.01) and in identification rates for bacteria (89.5% vs. 31.6%; p < 0.01), for viruses (57.9% vs. 0; p < 0.01), and for fungi (42.1% vs. 0; p < 0.01), respectively. mNGS identified a significantly higher proportion of mixed infections than culture (89.5% vs. 10.5%; p < 0.01). The anti-infection therapies were adjusted in two (33.3%) and 12 (76.9%) cases guided by culture and mNGS, respectively.ConclusionmNGS has more remarkable etiological diagnostic performance compared with urine culture for KTRs with RUTI to guide anti-infection strategies and, in turn, protect the graft. |
first_indexed | 2024-04-13T18:46:58Z |
format | Article |
id | doaj.art-24bdc1d5bc6146c5a4c58035ddb90759 |
institution | Directory Open Access Journal |
issn | 2296-2565 |
language | English |
last_indexed | 2024-04-13T18:46:58Z |
publishDate | 2022-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Public Health |
spelling | doaj.art-24bdc1d5bc6146c5a4c58035ddb907592022-12-22T02:34:33ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-08-011010.3389/fpubh.2022.901549901549Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipientsWenjing Duan0Yongguang Yang1Jingge Zhao2Tianzhong Yan3Xiangyong Tian4Department of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaBackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.MethodsNineteen KTRs with RUTI were collected in this study. The uropathogens were detected and compared by mNGS and urine culture, respectively. Modifications of the anti-infection strategy were also assessed.ResultsRich and diverse pathogens were revealed by mNGS. mNGS was significantly higher than culture in total positive rate (100.0% vs. 31.6%; p < 0.01) and in identification rates for bacteria (89.5% vs. 31.6%; p < 0.01), for viruses (57.9% vs. 0; p < 0.01), and for fungi (42.1% vs. 0; p < 0.01), respectively. mNGS identified a significantly higher proportion of mixed infections than culture (89.5% vs. 10.5%; p < 0.01). The anti-infection therapies were adjusted in two (33.3%) and 12 (76.9%) cases guided by culture and mNGS, respectively.ConclusionmNGS has more remarkable etiological diagnostic performance compared with urine culture for KTRs with RUTI to guide anti-infection strategies and, in turn, protect the graft.https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/fullmetagenomic next-generation sequencing (mNGS)kidney transplantationrecurrent urinary tract infection (RUTI)uropathogensanti-infective treatment |
spellingShingle | Wenjing Duan Yongguang Yang Jingge Zhao Tianzhong Yan Xiangyong Tian Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients Frontiers in Public Health metagenomic next-generation sequencing (mNGS) kidney transplantation recurrent urinary tract infection (RUTI) uropathogens anti-infective treatment |
title | Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
title_full | Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
title_fullStr | Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
title_full_unstemmed | Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
title_short | Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
title_sort | application of metagenomic next generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients |
topic | metagenomic next-generation sequencing (mNGS) kidney transplantation recurrent urinary tract infection (RUTI) uropathogens anti-infective treatment |
url | https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/full |
work_keys_str_mv | AT wenjingduan applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients AT yongguangyang applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients AT jinggezhao applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients AT tianzhongyan applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients AT xiangyongtian applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients |